These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6839062)

  • 21. Phenobarbitone-induced enlargement of the liver in the rat: its relationship to carbon tetrachloride-induced cirrhosis.
    Chatamra K; Proctor E
    Br J Exp Pathol; 1981 Jun; 62(3):283-8. PubMed ID: 7248170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
    Gerbracht U; Bursch W; Kraus P; Putz B; Reinacher M; Timmermann-Trosiener I; Schulte-Hermann R
    Carcinogenesis; 1990 Apr; 11(4):617-24. PubMed ID: 1691053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
    Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
    Digestion; 1979; 19(4):228-36. PubMed ID: 478204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of N-(4-methylbenzylthiocarbonyl)-L-phenylalanine (KF 1492), a new hypolipidemic drug, and clofibrate on lipids metabolism.
    Ishii A; Deguchi T; Marumo H; Tanaka M
    J Pharmacobiodyn; 1983 Mar; 6(3):170-6. PubMed ID: 6410039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Triglyceride synthesis and oleic acid catabolism by hepatic microsomes and mitochondria in clofibrate or procetofen-treated rats].
    Clouet E; Paris R
    Reprod Nutr Dev (1980); 1980; 20(3A):637-45. PubMed ID: 7349434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic effects of 4-chlorophenol in rats: comparison to clofibrate.
    Phornchirasilp S; Patel ST; Hanson JM; Newman HA; Witiak DT; Feller DR
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):139-46. PubMed ID: 2726779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of phenobarbitone on bile flow and bilirubin metabolism in man and the rat.
    Maxwell JD; Hunter J; Stewart DA; Carrella M; Williams R
    Digestion; 1973; 9(2):138-48. PubMed ID: 4203913
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic blood flow in phenobarbital-pretreated rats during halothane anesthesia and hypoxia.
    Ross WT; Daggy BP
    Anesth Analg; 1981 May; 60(5):306-9. PubMed ID: 7194595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azoreduction of N,N-dimethyl-4-aminoazobenzene (DAB) by rat hepatic microsomes. Selective induction by clofibrate.
    Raza H; Levine WG
    Drug Metab Dispos; 1986; 14(1):19-24. PubMed ID: 2868860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of thioridazine or chlorpromazine on increased hepatic NAD+ level in rats fed clofibrate, a hypolipidaemic drug.
    Shin M; Asada S; Mizumori N; Sano K; Umezawa C
    J Pharm Pharmacol; 1998 Apr; 50(4):431-6. PubMed ID: 9625489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translactational induction of CYP4A expression in 10.5-day neonatal rats by the hypolipidemic drug clofibrate.
    Simpson AE; Brammar WJ; Pratten MK; Elcombe CR
    Biochem Pharmacol; 1995 Dec; 50(12):2021-32. PubMed ID: 8849329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of phenobarbitone on hepatic microsomal enymes of the mmale rat.
    Pilcher CW; Thompson RP; Williams R
    Biochem Pharmacol; 1972 Jan; 21(1):129-33. PubMed ID: 5058702
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver blood flow. metabolic heat production and body temperature before, during and after phenobarbitone administration.
    Ohnhaus EE; Tilvis R
    Acta Hepatogastroenterol (Stuttg); 1976; 23(6):404-8. PubMed ID: 1007827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver. Dose--response relations.
    Kähönen MT; Ylikahri RH
    Atherosclerosis; 1979 Jan; 32(1):47-56. PubMed ID: 465113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of promethazine and isosafrole on rat-hepatic microsomal mono-oxygenase activity: comparison with classic inducers phenobarbitone and beta-naphthoflavone.
    Taylor G; Houston JB; Elcombe CR
    Xenobiotica; 1985 Mar; 15(3):243-9. PubMed ID: 4024659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triacylglycerol metabolism in the phenobarbital-treated rat.
    Goldberg DM; Roomi MW; Yu A; Roncari DA
    Biochem J; 1981 Apr; 196(1):337-46. PubMed ID: 7306075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of hypolipidemic drugs in the prevention of an orotic acid fatty liver.
    Elwood JC; Richert DA; Westerfeld WW
    Biochem Pharmacol; 1972 Apr; 21(8):1127-34. PubMed ID: 5034198
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse.
    Chianale J; Vollrath V; Wielandt AM; Amigo L; Rigotti A; Nervi F; Gonzalez S; Andrade L; Pizarro M; Accatino L
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):781-6. PubMed ID: 8615769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new multifunctional hydroxytyrosol-clofibrate with hypolipidemic, antioxidant, and hepatoprotective effects.
    Xie YD; Chen ZZ; Shao LH; Wang QT; Li N; Lu WF; Xu YH; Gao YQ; Guo LY; Liu HL; Li YP; Yang GD; Bian XL
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3119-3122. PubMed ID: 30119959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.